Latest filing published 23 Feb 2017 for BALCHEM CORP, €105k.
Insider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Frank Fitzpatrick: trading record in brief
Frank Fitzpatrick discloses dealings in Balchem Corp to SEC (Form 4). In total, 102 filings cover trades dated from 15 November 2006 to 21 February 2017.
In open-market terms, that means 2 purchases worth €701k on one side and 39 sales worth €20.8M on the other. Sales outweigh purchases by €20.1M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 16 share grants and 45 option exercises.
The newest entry dates from 23 February 2017: a share grant of €105k, in Balchem Corp. The last insider purchase was made public on 15 January 2014, 4,680 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Frank Fitzpatrick
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,307 shares@ US$85.4050.1% of flowCommon StockSEC:0001140361-17-008741:0
- 1,811 shares@ US$63.2749.9% of flowCommon StockSEC:0001140361-16-055817:0
- 14,935 shares@ US$29.06Common StockSEC:0001140361-15-024328:0
- 14,935 shares@ US$61.20Common StockSEC:0001140361-15-024328:1
- 14,000 shares@ US$32.21Common StockSEC:0001140361-15-020454:0
- 14,000 shares@ US$57.10Common StockSEC:0001140361-15-020454:1
- 14,000 shares@ US$32.21Common StockSEC:0001140361-15-015618:0
- 14,000 shares@ US$55.43Common StockSEC:0001140361-15-015618:1
- 12,250 shares@ US$21.39Common StockSEC:0001140361-15-012369:0
- 1,750 shares@ US$32.21Common StockSEC:0001140361-15-012369:1
- 14,000 shares@ US$56.07Common StockSEC:0001140361-15-012369:2
- 2,000 shares0Common StockSEC:0001140361-15-009414:0
- 14,000 shares@ US$21.39Common StockSEC:0001140361-15-007586:0
- 14,000 shares@ US$57.85Common StockSEC:0001140361-15-007586:1
- 14,000 shares@ US$21.39Common StockSEC:0001140361-15-001951:0
- 14,000 shares@ US$60.59Common StockSEC:0001140361-15-001951:1
- 12,250 shares@ US$17.28Common StockSEC:0001140361-14-045536:0
- 1,750 shares@ US$21.39Common StockSEC:0001140361-14-045536:1
- 14,000 shares@ US$63.01Common StockSEC:0001140361-14-045536:2
- 2,020 shares@ US$63.93Common StockSEC:0001140361-14-044921:0
- 14,000 shares@ US$17.28Common StockSEC:0001140361-14-042685:0
- 14,000 shares@ US$64.62Common StockSEC:0001140361-14-042685:1
- 14,000 shares@ US$17.28Common StockSEC:0001140361-14-038464:0
- 14,000 shares@ US$54.34Common StockSEC:0001140361-14-038464:1
- 6,250 shares@ US$13.61Common StockSEC:0001140361-14-035783:0
25 of 98 declarations
